SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
biotech firesales
An SI Board Since August 2001
Posts SubjectMarks Bans
3661 167 0
Emcee:  dalroi Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
3611Holy crap!! That author is Jim Larrick, from Cetus days. vpd.net What storiesscaram(o)uche-11/5/2018
3610had never heard of them or project, this turned up from 30 seconds of searching,scaram(o)uche-11/5/2018
3609CohBar (CWBR) off 34% on P1 injection site reactions for their lead program: &gtuck-11/5/2018
3608LGND ugly chart continue. No turn-around yet?Miljenko Zuanic-11/2/2018
3607CLVS off almost 25% on worse than expected earnings. CVLS might be a buy here otuck-10/31/2018
3606>> not capable to penetrate cancer environment << Well, that too. scaram(o)uche-10/23/2018
3605OK, you did mean mechanism of action. And I get your thesis now: not direct comtuck-10/23/2018
3604Thanks, I see my mistake with *5*---> *4*. I did not have preclinical data oMiljenko Zuanic-10/23/2018
3603Not 4261. Follow your own link. Now you've added to the typo mess. ;-) Oscaram(o)uche-10/23/2018
3602<Upon administration of RO6874281, the monoclonal antibody moiety recognizes Miljenko Zuanic-10/23/2018
3601at NIH/NCI it is listed as RO6874261 (Code # RG7461 as pipeline compound...RocheMiljenko Zuanic-10/23/2018
3600Were you referring to BofA Merrill Lynch or Mechanism Of Action? In either casetuck-10/23/2018
3599Search CT.gov using "RG7461".scaram(o)uche-10/23/2018
3598According to Roche's pipeline chart: "RG7461 is a targeted immunocytokituck-10/23/2018
3597Believe it's RO687*4*281. Typo, either Wainwright or the fly.scaram(o)uche-10/23/2018
3596Per MofA, it does not looks that RO6875281 will be combined with PD1(L1) as syneMiljenko Zuanic110/23/2018
3595NKTR Here's another angle from a different analyst: Nektar Therapeutics pltuck-10/23/2018
3594Somehow I do not believe that cascade of the events after intervening on IL-2/IFMiljenko Zuanic-10/23/2018
3593NKTR was also off yesterday, about 17% after a bear attack from Plainview, compatuck-10/23/2018
3592<As such, my strategy is to short the indexes as a hedge for long position inMiljenko Zuanic-10/22/2018
3591I think Dems only have to win the House to gridlock further GOP pharma and healttuck-10/22/2018
3590 <Even LOXO, whose data was stellar and soundly>IF Democrats win Congress&Miljenko Zuanic-10/22/2018
3589SLS got a huge pop a little while ago when they PRd that they would present thesDewDiligence_on_SI-10/22/2018
3588Sellas (SLS) also getting a thumping - of 16% - post ESMO, after apparently hypituck-10/22/2018
3587Adaptimmune (ADAP), another ESMO casualty, getting a justified 27% shellacking atuck-10/22/2018
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News